Filing Details

Accession Number:
0001213900-19-016455
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-21 16:34:42
Reporting Period:
2019-08-20
Accepted Time:
2019-08-21 16:34:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1711754 Inmune Bio Inc. INMB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421930 J David Moss C/O Inmune Bio Inc.,
1200 Prospect Street, Suite 525
La Jolla CA 92037
Cfo, Treasurer & Secretary No Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-20 77 $5.65 1,220,494 No 4 P Direct
Common Stock Acquisiton 2019-08-20 239 $5.65 1,220,733 No 4 P Direct
Common Stock Acquisiton 2019-08-20 2,000 $5.65 1,222,733 No 4 P Direct
Common Stock Acquisiton 2019-08-20 72 $5.65 1,222,805 No 4 P Direct
Common Stock Acquisiton 2019-08-20 236 $5.65 1,223,041 No 4 P Direct
Common Stock Acquisiton 2019-08-20 376 $5.65 1,223,417 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The Reporting Person purchased an aggregate of 3,000 shares of the Registrant's common stock on August 20, 2019 in six open market transactions.